Sernova Biotherapeutics
(OTC) SEOVF
Sernova Biotherapeutics Financials at a Glance
Market Cap
$35.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$11.84M
EPS (TTM)
-$0.03
P/E Ratio
-3.68
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$0.09
Volume
10,005
Open
$0.09
Price
$0.09
Volume
10,005
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.07 - $0.16
Estimated Earnings Date
Sep 10, 2026
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$0.09
Volume
10,005
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.07 - $0.16
Estimated Earnings Date
Sep 10, 2026
SEOVF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sernova Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jonathan M. N. Rigby, MBA
Website
www.sernova.comHeadquarters
London, ON N6G 4X8, GB
SEOVF Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
55.85%
Return on Capital
N/A
Return on Assets
-771.32%
Earnings Yield
-27.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$35.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
377.64M
Volume
10.01K
Avg. Volume
25.21K
Financials (TTM)
Gross Profit
-CA$204.64K
Operating Income
-CA$10.28M
EBITDA
-CA$10.04M
Operating Cash Flow
-CA$5.50M
Capital Expenditure
CA$0.00
Free Cash Flow
-CA$5.50M
Cash & ST Invst.
CA$1.05M
Total Debt
CA$2.45M
Sernova Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$4.43K
+87.2%
Gross Margin
0.00%
N/A
Market Cap
$35.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.08M
N/A
Employees
17
N/A
Net Income
-CA$3.23M
+14.6%
EBITDA
-CA$2.29M
+33.6%
Quarterly Fundamentals
Total Cash
CA$1.05M
-47.3%
Total Debt
CA$2.45M
-48.2%
Accounts Receivable
CA$116.80K
-73.0%
Inventory
CA$0.00
N/A
Long Term Debt
CA$229.16K
-81.2%
Short Term Debt
CA$2.22M
-36.9%
Return on Assets
-7.71%
N/A
Return on Invested Capital
1.09%
N/A
Free Cash Flow
-CA$2.21M
+42.5%
Operating Cash Flow
-CA$2.21M
+42.5%